Filing Details
- Accession Number:
- 0000950170-24-103807
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-09-05 11:50:56
- Reporting Period:
- 2024-09-03
- Accepted Time:
- 2024-09-05 11:50:56
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1515673 | Ultragenyx Pharmaceutical Inc. | RARE | Pharmaceutical Preparations (2834) | 272546083 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1603347 | Alan Theodore Huizenga | C/O Ultragenyx Pharmaceutical Inc. 60 Leveroni Court Novato CA 94949 | Svp, Chief Accounting Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2024-09-03 | 91 | $56.19 | 41,551 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Represents shares sold to pay required tax withholdings due to the vesting of RSUs.
- Includes 276 shares acquired under the Company's Amended and Restated 2014 Employee Stock Purchase Plan on April 30, 2024
- Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.
Billionaire Hedge Funds
